Microglia function in brain tumors

Journal of Neuroscience Research

Volumn 81, Issue 3, 2005, Pages 447-455

  Watters, Jyoti J ^a   Schartner, Jill M ^b   Badie, Behnam ^b,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c University of Wisconsin Health   (United States)

Author keywords

Brain macrophages; Brain neoplasms; Gliomas

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; FAS LIGAND; GROWTH FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROSTAGLANDIN E2; ROFECOXIB;

ANGIOGENESIS; ANTIGEN PRESENTATION; APOPTOSIS; BRAIN TUMOR; CELL FUNCTION; CELL INFILTRATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; GLIOMA; HELPER CELL; HUMAN; INNATE IMMUNITY; MACROPHAGE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; BRAIN NEOPLASMS; CELL COMMUNICATION; CELL MOVEMENT; CELL PROLIFERATION; CYTOKINES; GLIOMA; HUMANS; IMMUNE TOLERANCE; MICROGLIA; NEOVASCULARIZATION, PATHOLOGIC;

EID: 25444488717     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20485     Document Type: Short Survey

References (102)

1. Adachi K, Belser P, Bender H, Li D, Rodeck U, Benveniste EN, Woo D, Schmiegel WH, Herlyn D. 1992. Enhancement of epidermal growth factor receptor expression on glioma cells by recombinant tumor necrosis factor alpha. Cancer Immunol Immunother 34:370-376.
2. Aloisi F, De Simone R, Columba-Cabezas S, Penna G, Adorini L. 2000. Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells. J Immunol 164:1705-1712.
3. Aloisi F, Ria F, Penna G, Adorini L. 1998. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol 160:4671-4680.
4. Alterman RL, Stanley ER. 1994. Colony stimulating factor-1 expression in human glioma. Mol Chem Neuropathol 21:177-188.
5. Auf G, Carpentier AF, Chen L, Le Clanche C, Delattre JY. 2001. Implication of macrophages in tumor rejection induced by CpG-oligodeoxy- nucleotides without antigen. Clin Cancer Res 7:3540-3543.
6. Badie B, Bartley B, Schartner J. 2002. Differential expression of MHC class II and B7 costimulatory molecules by microglia in rodent gliomas. J Neuroimmunol 133:39-45.
7. Badie B, Schartner J, Klaver J, Vorpahl J. 1999. In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. Neurosurgery 44:1077-1082; discussion 1082-1083.
8. Badie B, Schartner J, Prabakaran S, Paul J, Vorpahl J. 2001. Expression of Fas ligand by microglia: possible role in glioma immune evasion. J Neuroimmunol 120:19-24.
9. Badie B, Schartner JM. 2000. Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. Neurosurgery 46:957-961; discussion 961-962.
10. Badie B, Schartner JM, Hagar AR, Prabakaran S, Peebles TR, Bartley B, Lapsiwala S, Resnick DK, Vorpahl J. 2003. Microglia cyclooxygenase-2 activity in experimental gliomas: possible role in cerebral edema formation. Clin Cancer Res 9:872-877.
11. Badie B, Schartner JM, Paul J, Bartley BA, Vorpahl J, Preston JK. 2000. Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study. J Neurosurg 93:634-639.
12. Berdel WE, de Vos S, Maurer J, Oberberg D, von Marschall Z, Schroeder JK, Li J, Ludwig WD, Kreuser ED, Thiel E, et al. 1992. Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expressing c-kit protooncogene. Cancer Res 52:3498-3502.
13. Briers TW, Desmaretz C, Vanmechelen E. 1994. Generation and characterization of mouse microglial cell lines. J Neuroimmunol 52:153-164.
14. Brooks WH, Netsky MG, Normansell DE, Horwitz DA. 1972. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med 136:1631-1647.
15. Carpentier AF, Xie J, Mokhtari K, Delattre JY. 2000. Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs. Clin Cancer Res 6:2469-2473.
16. Constam DB, Philipp J, Malipiero UV, ten Dijke P, Schachner M, Fontana A. 1992. Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia. J Immunol 148:1404-1410.
17. Cross AK, Woodroofe MN. 1999. Chemokine modulation of matrix metalloproteinase and TIMP production in adult rat brain microglia and a human microglial cell line in vitro. Glia 28:183-189.
18. Desbaillets I, Diserens AC, Tribolet N, Hamou MF, Van Meir EG. 1997. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J Exp Med 186:1201-1212.
19. Esteve PO, Chicoine E, Robledo O, Aoudjit F, Descoteaux A, Potworowski EF, St-Pierre Y. 2002. Protein kinase C-zeta regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-alpha in glioma cells via NF-kappa B. J Biol Chem 277:35150-35155.
20. Esteve PO, Tremblay P, Houde M, St-Pierre Y, Mandeville R. 1998. In vitro expression of MMP-2 and MMP-9 in glioma cells following exposure to inflammatory mediators. Biochim Biophys Acta 1403:85-96.
21. Flügel A, Bradl M, Kreutzberg GW, Graeber MB. 2001. Transformation of donor-derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy. J Neurosci Res 66:74-82.
22. Flugel A, Labeur MS, Grasbon-Frodl EM, Kreutzberg GW, Graeber MB. 1999. Microglia only weakly present glioma antigen to cytotoxic T cells. Int J Dev Neurosci 17:547-556.
23. Forstreuter F, Lucius R, Mentlein R. 2002. Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells. J Neuroimmunol 132:93-98.
24. Frei K, Piani D, Malipiero UV, Van Meir E, de Tribolet N, Fontana A. 1992. Granulocyte-macrophage colony-stimulating factor (GM-CSF) production by glioblastoma cells. Despite the presence of inducing signals GM-CSF is not expressed in vivo. J Immunol 148:3140-3146.
25. Galasso JM, Stegman LD, Blaivas M, Harrison JK, Ross BD, Silverstein FS. 2000. Experimental gliosarcoma induces chemokine receptor expression in rat brain. Exp Neurol 161:85-95.
26. Giulian D, Ingeman JE. 1988. Colony-stimulating factors as promoters of ameboid microglia. J Neurosci 8:4707-4717.
27. Goswami S, Gupta A, Sharma SK. 1998. Interleukin-6-mediated autocrine growth promotion in human glioblastoma multiforme cell line U87MG. J Neurochem 71:1837-1845.
28. Graeber MB, Bise K, Mehraein P. 1994. CR3/43, a marker for activated human microglia: application to diagnostic neuropathology. Neuropathol Appl Neurobiol 20:406-408.
29. Guillemin GJ, Brew BJ. 2004. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol 75:388-397.
30. Halfter H, Kremerskothen J, Weber J, Hacker-Klom U, Barnekow A, Ringelstein EB, Stogbauer F. 1998a. Growth inhibition of newly established human glioma cell lines by leukemia inhibitory factor. J Neurooncol 39:1-18.
31. Halfter H, Lotfi R, Westermann R, Young P, Ringelstein EB, Stogbauer FT. 1998b. Inhibition of growth and induction of differentiation of glioma cell lines by oncostatin M (OSM). Growth Factors 15:135-147.
32. Hamel W, Westphal M. 1997. The road less travelled: c-kit and stem cell factor. J Neurooncol 35:327-333.
33. Hao C, Parney IF, Roa WH, Turner J, Petruk KC, Ramsay DA. 2002. Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation. Acta Neuropathol 103:171-178.
34. Helseth E, Unsgaard G, Dalen A, Fure H, Skandsen T, Odegaard A, Vik R. 1988. Amplification of the epidermal growth factor receptor gene in biopsy specimens from human intracranial tumours. Br J Neurosurg 2:217-225.
35. Huettner C, Czub S, Kerkau S, Roggendorf W, Tonn JC. 1997. Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro. Anticancer Res 17:3217-3224.
36. Jeffers M, Rao MS, Rulong S, Reddy JK, Subbarao V, Hudson E, Vande Woude GF, Resau JH. 1996a. Hepatocyte growth factor/scatter factor-Met signaling induces proliferation, migration, and morphogenesis of pancreatic oval cells. Cell Growth Differ 7:1805-1813.
37. Jeffers M, Rong S, Woude GF. 1996b. Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. J Mol Med 74:505-513.
38. Kielian T, van RN, Hickey WF. 2002. MCP-1 expression in CNS-1 astrocytoma cells: implications for macrophage infiltration into tumors in vivo. J Neurooncol 56:1-12.
39. Kleihues P, Soylemezoglu F, Schauble B, Scheithauer BW, Burger PC. 1995. Histopathology, classification, and grading of gliomas. Glia 15:211-221.
40. Koochekpour S, Jeffers M, Rulong S, Taylor G, Klineberg E, Hudson EA, Resau JH, Vande Woude GF. 1997. Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res 57:5391-5398.
41. Kunkel P, Muller S, Schirmacher P, Stavrou D, Fillbrandt R, Westphal M, Lamszus K. 2001. Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas. Neuro-oncol 3: 82-88.
42. Kuppner MC, Sawamura Y, Hamou MF, de Tribolet N. 1990. Influence of PGE2- and cAMP-modulating agents on human glioblastoma cell killing by interleukin-2-activated lymphocytes. J Neurosurg 72:619-625.
43. Lafuente JV, Adan B, Alkiza K, Garibi JM, Rossi M, Cruz-Sanchez FF. 1999. Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-beta (PDGFR-beta) in human gliomas. J Mol Neurosci 13:177-185.
44. Lai JP, Zhan GX, Campbell DE, Douglas SD, Ho WZ. 2000. Detection of substance P and its receptor in human fetal microglia. Neuroscience 101:1137-1144.
45. Leung SY, Wong MP, Chung LP, Chan AS, Yuen ST. 1997. Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathol 93:518-527.
46. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, Schlessinger J. 1985. Amplification and overexpression of the EGF receptor gene in primary human glioblastomas. J Cell Sci Suppl 3:161-172.
47. Louis DN, Pomeroy SL, Cairncross JG. 2002. Focus on central nervous system neoplasia. Cancer Cell 1:125-128.
48. Luber-Narod J, Kage R, Leeman SE. 1994. Substance P enhances the secretion of tumor necrosis factor-alpha from neuroglial cells stimulated with lipopolysaccharide. J Immunol 152:819-824.
49. Mahaley MS Jr, Brooks WH, Roszman TL, Bigner DD, Dudka L, Richardson S. 1977. Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients. J Neurosurg 46:467-476.
50. Martin FC, Anton PA, Gornbein JA, Shanahan F, Merrill JE. 1993. Production of interleukin-1 by microglia in response to substance P: role for a non-classical NK-1 receptor. J Neuroimmunol 42:53-60.
51. Mishima K, Higashiyama S, Asai A, Yamaoka K, Nagashima Y, Taniguchi N, Kitanaka C, Kirino T, Kuchino Y. 1998. Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas. Acta Neuropathol 96:322-328.
52. Mueller MM, Herold-Mende CC, Riede D, Lange M, Steiner HH, Fusenig NE. 1999. Automne growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression. Am J Pathol 155:1557-1567.
53. Murphy GM Jr, Bitting L, Majewska A, Schmidt K, Song Y, Wood CR. 1995. Expression of interleukin-11 and its encoding mRNA by glioblastoma cells. Neurosci Lett 196:153-156.
54. Naganuma H, Sasaki A, Satoh E, Nagasaka M, Nakano S, Isoe S, Nukui H. 1996. Modulation of transforming growth factor-beta secretion from malignant glioma cells by interleukin-1 beta. Neurol Med Chir (Tokyo) 36:145-150.
55. Naganuma H, Sasaki A, Satoh E, Nagasaka M, Nakano S, Isoe S, Nukui H. 1998. Down-regulation of transforming growth factor-beta and interleukin-10 secretion from malignant glioma cells by cytokines and anticancer drugs. J Neurooncol 39:227-236.
56. Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J. 1995. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83:298-307.
57. Nitta T, Sato K, Allegretta M, Brocke S, Lim M, Mitchell DJ, Steinman L. 1992. Expression of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor genes in human astrocytoma cell lines and in glioma specimens. Brain Res 571:19-25.
58. Nolle C, Kirchhoff F, Kettenmann H. 1997. Epidermal growth factor is a motility factor for microglial cells in vitro: evidence for EGF receptor expression. Eur J Neurosci 9:1690-1698.
59. Olofsson A, Miyazono K, Kanzaki T, Colosetti P, Engstrom U, Heldin C. 1992. Transforming growth factor-beta 1, -beta 2, and -beta 3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes. J Biol Chem 267:19482-19488.
60. Palma C, Maggi CA. 2000. The role of tachykinins via NK1 receptors in progression of human gliomas. Life Sci 67:985-1001.
61. Palma C, Nardelli F, Manzini S, Maggi CA. 1999. Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors. Br J Cancer 79:236-243.
62. Penfield W. 1925. Microglia and the process of phagocytosis in gliomas. Am J Pathol 1:77-97.
63. Platten M, Kretz A, Naumann U, Aulwurm S, Egashira K, Isenmann S, Weller M. 2003. Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas. Ann Neurol 54:388-392.
64. Platten M, Wick W, Weller M. 2001. Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape. Microsc Res Tech 52:401-410.
65. Prados MD, Levin V. 2000. Biology and treatment of malignant glioma. Semin Oncol 27(Suppl):1-10.
66. Prahl M, Nederman T, Carlsson J, Sjodin L. 1991. Binding of epidermal growth factor (EGF) to a cultured human glioma cell line. J Recept Res 11:791-812.
67. Rasley A, Bost KL, Olson JK, Miller SD, Marriott I. 2002. Expression of functional NK-1 receptors in murine microglia. Glia 37:258-267.
68. Rempel SA, Dudas S, Ge S, Gutierrez JA. 2000. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 6:102-111.
69. Rezaie P, Trillo-Pazos G, Everall IP, Male DK. 2002. Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS. Glia 37:64-75.
70. Rio-Hortega PD, Asua FJ. 1921. Sobre la fagocytosis en los tumores y en otros procesos patologicos. Arch Cardiol Hematol 2:161-220.
71. Robins HI, Peterson CG, Mehta MP. 2003. Combined modality treatment for central nervous system malignancies. Semin Oncol 30(Suppl):11-22.
72. Roggendorf W, Strupp S, Paulus W. 1996. Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol 92:288-293.
73. Rossi ML, Cruz-Sanchez F, Hughes JT, Esiri MM, Coakham HB, Moss TH. 1988. Mononuclear cell infiltrate and HLA-DR expression in low grade astrocytomas. An immunohistological study of 23 cases. Acta Neuropathol (Berl) 76:281-286.
74. Rossi ML, Hughes JT, Esiri MM, Coakham HB, Brownell DB. 1987. Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol (Berl) 74:269-277.
75. Rossi ML, Jones NR, Candy E, Nicoll JA, Compton JS, Hughes JT, Esiri MM, Moss TH, Cruz-Sanchez FF, Coakham HB. 1989. The mononuclear cell infiltrate compared with survival in high-grade astrocytomas. Acta Neuropathol (Berl) 78:189-193.
76. Ryuto M, Ono M, Izumi H, Yoshida S, Weich HA, Kohno K, Kuwano M. 1996. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem 271:28220-28228.
77. Saijo Y, Tanaka M, Miki M, Usui K, Suzuki T, Maemondo M, Hong X, Tazawa R, Kikuchi T, Matsushima K, Nukiwa T. 2002. Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction. J Immunol 169:469-475.
78. Schartner J, Hagar AR, Zhang L, Van Handel M, Salmon J, Badie B. 2004. Altered induction of MHC class II expression in tumor-associated microglia (submitted).
79. Sedgwick JD, Schwender S, Imrich H, Dorries R, Butcher GW, ter Meulen V. 1991. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Nad Acad Sci USA 88:7438-7442.
80. Shinonaga M, Chang CC, Suzuki N, Sato M, Kuwabara T. 1988. Immunohistological evaluation of macrophage infiltrates in brain tumors. Correlation with peritumoral edema. J Neurosurg 68:259-265.
81. Stanulla M, Welte K, Hadam MR, Pietsch T. 1995. Coexpression of stem cell factor and its receptor c-Kit in human malignant glioma cell lines. Acta Neuropathol 89:158-165.
82. Steck PA, Lee P, Hung MC, Yung WK. 1988. Expression of an altered epidermal growth factor receptor by human glioblastoma cells. Cancer Res 48:5433-5439.
83. Streit WJ. 1994. Cellular immune response in brain tumors. Neuropathol Appl Neurobiol 20:205-206.
84. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. 1994. Macrophages and angiogenesis. J Leukoc Biol 55:410-422.
85. Suzumura A, Sawada M, Yamamoto H, Marunouchi T. 1993. Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. J Immunol 151:2150-2158.
86. Tada M. 1992. [In vitro and in vivo immunobiological responses of glioblastoma to human natural tumor necrosis factor-alpha]. Hokkaido Igaku Zasshi 67:498-511.
87. Tada M, Diserens AC, Desbaillets I, de Tnbolet N. 1994. Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction. J Neurosurg 80:1063-1073.
88. Tada M, Sawamura Y, Sakuma S, Suzuki K, Ohta H, Aida T, Abe H. 1993. Cellular and cytokine responses of the human central nervous system to intracranial administration of tumor necrosis factor alpha for the treatment of malignant gliomas. Cancer Immunol Immunother 36:251-259.
89. Torp SH, Helseth E, Dalen A, Unsgaard G. 1991. Epidermal growth factor receptor expression in human gliomas. Cancer Immunol Immunother 33:61-64.
90. Tran CT, Wolz P, Egensperger R, Kosel S, Imai Y, Bise K, Kohsaka S, Mehraein P, Graeber MB. 1998. Differential expression of MHC class II molecules by microglia and neoplastic astroglia: relevance for the escape of astrocytoma cells from immune surveillance. Neuropathol Appl Neurobiol 24:293-301.
91. Tsai JC, Goldman CK, Gillespie GY. 1995. Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg 82:864-873.
92. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y, Dinarello CA, Apte RN. 2003. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 100:2645-2650.
93. Wagner S, Czub S, Greif M, Vince GH, Suss N, Kerkau S, Rieckmann P, Roggendorf W, Roosen K, Tonn JC. 1999. Microglial/macrophage expression of interleukin 10 in human glioblastomas. Int J Cancer 82:12-16.
94. Westphal M, Neuss M, Herrmann HD. 1986. Prostaglandins: antiproliferative effect of PGD 2 on cultured human glioma cells. Acta Neurochir (Wien) 83:56-61.
95. Wierzba-Bobrowicz T, Kuchna I, Matyja E. 1994. Reaction of microglial cells in human astrocytomas (preliminary report). Folia Neuropathol 32:251-252.
96. Yamada T, Tsubouchi H, Daikuhara Y, Prat M, Comoglio PM, McGeer PL, McGeer EG. 1994. Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissues. Brain Res 637:308-312.
97. Yamanaka R, Tanaka R, Saitoh T, Okoshi S. 1994. Cytokine gene expression on glioma cell lines and specimens. J Neurooncol 21:243-247.
98. Zhang L, Himi T, Murota S. 2000. Induction of hepatocyte growth factor (HGF) in rat microglial cells by prostaglandin E. J Neurosci Res 62:389-395.
99. Zhang SC, Fedoroff S. 1997. Cellular localization of stem cell factor and c-kit receptor in the mouse nervous system. J Neurosci Res 47:1-15.
100. Zhang SC, Fedoroff S. 1998. Modulation of microglia by stem cell factor. J Neurosci Res 53:29-37.
101. Zhang SC, Fedoroff S. 1999. Expression of stem cell factor and c-kit receptor in neural cells after brain injury. Acta Neuropathol 97:393-398.
102. Zhou Y, Larsen PH, Hao C, Yong VW. 2002. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 277:49481-49487.